XML 37 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Convertible preferred stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balance, Shares at Mar. 31, 2018 6,767,600 13,732,400        
Beginning Balance, Amount at Mar. 31, 2018 $ 6,768 $ 137 $ 13,117,767 $ (8,973,082) $ (40,625) $ 4,110,965
Conversion of preferred stock into common stock, Shares 13,732,400 (13,732,400)        
Conversion of preferred stock into common stock, Amount $ 13,732 $ (137) (13,595)
Issuance of common shares and warrants under public offering -net of offering costs, Shares 194,206        
Issuance of common shares and warrants under public offering -net of offering costs, Amount $ 194 1,691,304 1,691,498
Issuance of common shares under ATM financing, net, Shares 23,500        
Issuance of common shares under ATM financing, net, Amount $ 23 293,979 294,002
Exercise of warrants, Shares 5,000        
Exercise of warrants, Amount $ 5 495 500
Stock-based compensation 5 199,496 199,501
Foreign currency translation adjustment (311,718) (311,718)
Net loss (2,828,318) (2,828,318)
Ending Balance, Shares at Dec. 31, 2018 20,727,456        
Ending Balance, Amount at Dec. 31, 2018 $ 20,727 15,289,446 (11,801,400) (352,343) 3,156,430
Beginning Balance, Shares at Sep. 30, 2018 20,505,000          
Beginning Balance, Amount at Sep. 30, 2018 $ 20,505   13,219,168 (10,875,510) (313,717) 2,050,446
Issuance of common shares and warrants under public offering -net of offering costs, Shares 194,206          
Issuance of common shares and warrants under public offering -net of offering costs, Amount $ 194   1,691,304 1,691,498
Issuance of common shares under ATM financing, net, Shares 23,500          
Issuance of common shares under ATM financing, net, Amount $ 23   293,979 294,002
Stock-based compensation, Shares 4,750          
Stock-based compensation $ 5   84,995 85,000
Foreign currency translation adjustment   (38,626) (38,626)
Net loss   (925,889) (925,889)
Ending Balance, Shares at Dec. 31, 2018 20,727,456        
Ending Balance, Amount at Dec. 31, 2018 $ 20,727 15,289,446 (11,801,400) (352,343) 3,156,430
Beginning Balance, Shares at Mar. 31, 2019 20,765,592        
Beginning Balance, Amount at Mar. 31, 2019 $ 20,766 15,971,905 (13,425,879) (339,888) 2,226,904
Issuance of common shares under ATM financing, net, Shares 14,338        
Issuance of common shares under ATM financing, net, Amount $ 14 142,903 142,917
Exercise of warrants, Shares 2,500        
Exercise of warrants, Amount $ 3 25,997 26,000
Reverse split adjustment, Shares 418        
Reverse split adjustment, Amount
Restricted shares issued as stock-based compensation, Shares 25,500        
Restricted shares issued as stock-based compensation, Amount $ 25 231,924 231,949
Foreign currency translation adjustment (48,986) (48,986)
Net loss (2,813,312) (2,813,312)
Ending Balance, Shares at Dec. 31, 2019 20,808,348        
Ending Balance, Amount at Dec. 31, 2019 $ 20,808 16,372,729 (16,239,191) (388,874) (234,528)
Beginning Balance, Shares at Sep. 30, 2019 20,802,930          
Beginning Balance, Amount at Sep. 30, 2019 $ 20,803   16,332,734 (15,794,184) (363,040) 196,313
Restricted shares issued as stock-based compensation to consultants and investor relations, Shares 5,000          
Restricted shares issued as stock-based compensation to consultants and investor relations, Amount $ 5   39,995 40,000
Reverse split adjustment, Shares 418          
Reverse split adjustment, Amount  
Foreign currency translation adjustment   (25,834) (25,834)
Net loss   (445,007) (445,007)
Ending Balance, Shares at Dec. 31, 2019 20,808,348        
Ending Balance, Amount at Dec. 31, 2019 $ 20,808 $ 16,372,729 $ (16,239,191) $ (388,874) $ (234,528)